Get the Weekly Intelligence Brief — top committee picks every Sunday.
UNH · NYSE · STOCK

UnitedHealth Group (UNH) Stock Analysis

Healthcare Updated August 23, 2026
$390.12
52W $255.97 – $461.62
48/100
$354.28B
25.1
0.63
AI Committee Verdict
Watch
48/100
Conviction: Contested · 33% agreement · 6 analysts
+18.2%
-21.9%
0.83:1
Contested

Is UNH Bullish or Bearish?

Mixed. Innellis AI committee rates UnitedHealth Group (UNH) Watch with a composite score of 48/100 , based on 6 analysts with 33% agreement. Last updated August 23, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +11.78 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -8.22 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Growth Analyst remains cautious — eps declining -32.7% yoy despite any revenue growth. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
Insufficient data for bull case.
Bear Case
  • P/E of 25.6 is moderate-to-rich — Value
  • EPS declining -32.7% YoY despite any revenue growth — Growth
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
  • MACD histogram negative -- bearish momentum — Technical
  • Current ratio of 0.89 is tight -- limited short-term liquidity cushion — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 23, 2026
Overall Committee Score
48/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 96%
of 192 Healthcare peers
Value Analyst neutral
48 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− P/E of 25.6 is moderate-to-rich
Growth Analyst bearish
32 / 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -32.7% YoY despite any revenue growth
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Current ratio of 0.89 is tight -- limited short-term liquidity cushion
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
62 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3069.37)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 48.2 to 48.2.

Comparing 2026-08-22 to 2026-08-23 (1 day apart).

Technical Analysis

RSI (14)
34.7
Neutral
MACD Histogram
-2.394
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$304.58
Resistance
$460.95
Bollinger %B
0.17
Inside Bands
Price vs Moving Averages
EMA 9
$395.12 Below
EMA 21
$403.41 Below
EMA 50
$403.77 Below
EMA 200
$371.16 Above

Fundamental Analysis

Valuation
77
Growth
67
Profitability
31
Financial Health
63
Cash Flow
70
Valuation
P/E Ratio 25.1×
P/B Ratio 3.38×
PEG Ratio -0.76
Dividend Yield 2.29%
52W High $461.62
52W Low $255.97
Quality & Growth
ROE 1281.0%
ROA 389.4%
Gross Margin 2248.6%
Operating Margin 481.6%
Revenue Growth YoY
Debt / Equity 0.70
AI Fundamental Assessment
P/E ratio of 25.1 (moderate relative to a 15-40x range); Price-to-book of 3.4x; PEG ratio of -0.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 12.8%; Return on assets of 3.9%; Net margin of 3.1%; Gross margin of 22.5%; Current ratio of 1.24 (tight short-term liquidity); Debt-to-equity of 0.70; Free cash flow per share is positive (26.07); Most recent quarter beat estimates by 28.8%; 2 consecutive earnings beats; EPS growth decelerating (+242.7% -> -11.8% QoQ); Average YoY EPS growth of 56.4%; Analyst estimates rising over recent quarters
Get the Full UNH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime